Evidence map›Paper›PMID 42726401›Full record

ArticleInterdisciplinary sciences, computational life sciences2026

Beyond Structural Representations: A Semantic-Relational Graph Neural Network for Polypharmacy Side Effect Prediction.

Fatma Zahra Abdeldjouad, Menaouer Brahami

Abstract read
PubMed Publisher
In one paragraph

Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fatma Zahra AbdeldjouadLABAB Laboratory, Computer Systems Engineering Department, National Polytechnic School of Oran - Maurice Audin, 31006, Oran, Algeria. fatma-zahra.abdeldjouad@enp-oran.dz.ORCID http://orcid.org/0009-0006-4474-7837
Menaouer BrahamiLABAB Laboratory, Computer Systems Engineering Department, National Polytechnic School of Oran - Maurice Audin, 31006, Oran, Algeria.ORCID http://orcid.org/0000-0003-0045-9797

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The concurrent use of several medications, known as polypharmacy, has increased in prevalence, especially among older adults with complex health conditions. Despite its effectiveness, this therapeutic strategy increases the risk of Polypharmacy Side Effects (PSEs), leading to substantial clinical and economic burden. Recent deep learning methods have integrated graph neural networks with pretrained language models to predict PSEs. However, these approaches rely on relation-agnostic decoders and fail to consider the pharmacological context of each PSE type. To address these issues, we propose SIREN, a semantic-relational graph neural network that integrates semantic embeddings from ChemBERTa and BioBERT with a multirelational biomedical graph structure. The model employs a relation-specific decoder to adapt the score of each drug pair based on the target side effect type. Experimental evaluation on the TWOSIDES dataset demonstrated high AUROC and AUPRC, outperforming current state-of-the-art models under the transductive setting and remaining competitive under inductive settings. Ablation studies further validated the importance of the relation-specific decoding mechanism and pre-trained node embeddings. By integrating semantic representations with graph-based reasoning, this study establishes an innovative framework for data-driven pharmacovigilance, thereby enhancing patient safety, reducing healthcare costs, and supporting regulatory compliance.

Indexed as

Heterogeneous graph neural networksPharmacovigilancePolypharmacy side effectsPretrained language modelsRelation-specific decoder

Identifiers

PMID42726401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.